KEGG   PATHWAY: uar04940
Entry
uar04940                    Pathway                                
Name
Type I diabetes mellitus - Ursus americanus (American black bear)
Description
Type I diabetes mellitus is a disease that results from autoimmune destruction of the insulin-producing beta-cells. Certain beta-cell proteins act as autoantigens after being processed by antigen-presenting cell (APC), such as macrophages and dendritic cells, and presented in a complex with MHC-II molecules on the surface of the APC. Then immunogenic signals from APC activate CD4+ T cells, predominantly of the Th1 subset. Antigen-activated Th1 cells produce IL-2 and IFNgamma. They activate macrophages and cytotoxic CD8+ T cells, and these effector cells may kill islet beta-cells by one or both of two types of mechanisms: (1) direct interactions of antigen-specific cytotoxic T cells with a beta-cell autoantigen-MHC-I complex on the beta-cell, and (2) non-specific inflammatory mediators, such as free radicals/oxidants and cytokines (IL-1, TNFalpha, TNFbeta, IFNgamma).
Type I diabetes is a polygenic disease. One of the principle determining genetic factors in diabetes incidence is the inheritance of mutant MHC-II alleles. Another plausible candidate gene is the insulin gene.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
uar04940  Type I diabetes mellitus
uar04940

Organism
Ursus americanus (American black bear) [GN:uar]
Gene
123775502  INS; insulin [KO:K04526]
123787432  glutamate decarboxylase 1-like [KO:K01580] [EC:4.1.1.15]
123780849  GAD1; glutamate decarboxylase 1 [KO:K01580] [EC:4.1.1.15]
123778151  GAD2; glutamate decarboxylase 2 [KO:K01580] [EC:4.1.1.15]
123788736  PTPRN2; receptor-type tyrosine-protein phosphatase N2 [KO:K07817] [EC:3.1.3.48]
123779463  PTPRN; receptor-type tyrosine-protein phosphatase-like N isoform X1 [KO:K07817] [EC:3.1.3.48]
123793170  CPE; carboxypeptidase E [KO:K01294] [EC:3.4.17.10]
123798166  HSPD1; 60 kDa heat shock protein, mitochondrial [KO:K04077] [EC:5.6.1.7]
123789242  ICA1; islet cell autoantigen 1 isoform X1 [KO:K19863]
123794091  HLA class II histocompatibility antigen, DQ beta 1 chain-like [KO:K06752]
123794092  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
123790938  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
123790941  HLA class II histocompatibility antigen, DM alpha chain isoform X1 [KO:K06752]
123790942  HLA class II histocompatibility antigen, DM beta chain isoform X1 [KO:K06752]
123790948  HLA class II histocompatibility antigen, DO beta chain isoform X1 [KO:K06752]
123790949  DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
123790950  boLa class II histocompatibility antigen, DQB*0101 beta chain [KO:K06752]
123790951  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
123790953  DLA class II histocompatibility antigen, DR-1 beta chain [KO:K06752]
123790954  HLA class II histocompatibility antigen, DR alpha chain [KO:K06752]
123791051  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP alpha 1 chain [KO:K06752]
123784031  CD80; T-lymphocyte activation antigen CD80 [KO:K05412]
123802090  CD86; T-lymphocyte activation antigen CD86 isoform X1 [KO:K05413]
123798321  CD28; T-cell-specific surface glycoprotein CD28 [KO:K06470]
123801580  IL12A; interleukin-12 subunit alpha [KO:K05406]
123788629  IL12B; interleukin-12 subunit beta [KO:K05425]
123793114  IL2; interleukin-2 [KO:K05429]
123787294  IFNG; interferon gamma [KO:K04687]
123785045  class I histocompatibility antigen, Gogo-OKO alpha chain-like [KO:K06751]
123793445  HLA class I histocompatibility antigen, B alpha chain-like [KO:K06751]
123794160  uncharacterized protein LOC123794160 [KO:K06751]
123780238  H-2 class I histocompatibility antigen, Q10 alpha chain-like [KO:K06751]
123791023  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
123791025  LOW QUALITY PROTEIN: class I histocompatibility antigen, Gogo-B*0103 alpha chain-like [KO:K06751]
123791026  DLA class I histocompatibility antigen, A9/A9 alpha chain-like isoform X1 [KO:K06751]
123791029  DLA class I histocompatibility antigen, A9/A9 alpha chain-like [KO:K06751]
123803052  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
123795545  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
123782929  PRF1; LOW QUALITY PROTEIN: perforin-1 [KO:K07818]
123795665  granzyme B-like [KO:K01353] [EC:3.4.21.79]
123795689  LOW QUALITY PROTEIN: mast cell protease 1A-like [KO:K01353] [EC:3.4.21.79]
123791077  LTA; lymphotoxin-alpha [KO:K05468]
123791076  TNF; tumor necrosis factor [KO:K03156]
123799742  IL1A; interleukin-1 alpha [KO:K04383]
123799741  IL1B; interleukin-1 beta [KO:K04519]
Compound
C00027  Hydrogen peroxide
C00533  Nitric oxide
C00704  Superoxide
Reference
PMID:9719467
  Authors
Rabinovitch A, Suarez-Pinzon WL.
  Title
Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
  Journal
Biochem Pharmacol 55:1139-49 (1998)
DOI:10.1016/S0006-2952(97)00492-9
Reference
  Authors
Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P
  Title
Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.
  Journal
Am J Hum Genet 69:820-30 (2001)
DOI:10.1086/323501
Reference
PMID:8072542
  Authors
Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al.
  Title
A genome-wide search for human type 1 diabetes susceptibility genes.
  Journal
Nature 371:130-6 (1994)
DOI:10.1038/371130a0
Reference
PMID:8786033
  Authors
Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Shima K, Ogihara T.
  Title
Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.
  Journal
Diabetologia 38:1493-5 (1995)
DOI:10.1007/BF00400620
Reference
  Authors
Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H.
  Title
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
  Journal
J Exp Med 197:1635-44 (2003)
DOI:10.1084/jem.20030215
Reference
  Authors
Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS.
  Title
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
  Journal
Nature 435:220-3 (2005)
DOI:10.1038/nature03523
Reference
  Authors
Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA.
  Title
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.
  Journal
Nature 435:224-8 (2005)
DOI:10.1038/nature03625
Reference
  Authors
Lieberman SM, DiLorenzo TP.
  Title
A comprehensive guide to antibody and T-cell responses in type 1 diabetes.
  Journal
Tissue Antigens 62:359-77 (2003)
DOI:10.1034/j.1399-0039.2003.00152.x
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Related
pathway
uar04210  Apoptosis
uar04660  T cell receptor signaling pathway
KO pathway
ko04940   
LinkDB

DBGET integrated database retrieval system